Skip to main content
OpenTrials

Clinical trial condition

Wet Macular Degeneration

Explore clinical trials studying Wet Macular Degeneration. Study availability and eligibility vary by location and protocol.

76 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Wet Macular Degeneration trial results

Completed

A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT06190093

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Clinical Site Arcadia, California, United States
  • Clinical Site Bakersfield, California, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Huntington Beach, California, United States
View all 61 locations
View Trial Details
Completed

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

NCT04516278

Conditions
Age-Related Macular Degeneration, BRVO - Branch Retinal Vein Occlusion, Cardiovascular Diseases, +12 more
Locations
  • Clinical Site Tucson, Arizona, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Glendale, California, United States
  • Clinical Site Long Beach, California, United States
View all 20 locations
View Trial Details
Completed

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

NCT05637255

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
Locations
  • SYL1801 Investigative Site Brno, Czechia
  • SYL1801 Investigative Site Chomutov, Czechia
  • SYL1801 Investigative Site Frýdek-Místek, Czechia
  • SYL1801 Investigative Site Kyjov, Czechia
View all 16 locations
View Trial Details
Completed

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

NCT04679935

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Regensburg, Bavaria, Germany
  • Novartis Investigative Site Frankfurt am Main, Hesse, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Bonn, Germany
View all 19 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

NCT03823287

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +2 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 161 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)

NCT03823300

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +2 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Arizona Retina and Vitreous Consultants Phoenix, Arizona, United States
  • Northern California Retina Vitreous Associates Mountain View, California, United States
  • Retinal Consultants Med Group Sacramento, California, United States
View all 137 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

NCT04635800

Conditions
Cardiovascular Diseases, Diabetic Macular Edema, Embolism and Thrombosis, +12 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Honolulu, Hawaii, United States
  • Novartis Investigative Site Hagerstown, Maryland, United States
  • Novartis Investigative Site Austin, Texas, United States
View Trial Details
Completed

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

NCT04774926

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site Acquaviva delle Fonti, BA, Italy
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Cagliari, CA, Italy
View all 20 locations
View Trial Details
Completed

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

NCT05269966

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Asarwa, Ahmedabad, India
  • Novartis Investigative Site Ahmedabad, Gujarat, India
  • Novartis Investigative Site Bangalore, Karnataka, India
  • Novartis Investigative Site Chennai, Tamil Nadu, India
View Trial Details

Related conditions